Your browser doesn't support javascript.
loading
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.
Bermejo-Rodriguez, Camino; Araos Henríquez, Joaquín; Caligiuri, Giuseppina; Pinto Teles, Sara; Park, Youngkyu; Evans, Anthony; Barrera, Lawrence N; Neesse, Albrecht; Grützmann, Robert; Aust, Daniela; Rümmele, Petra; Knösel, Thomas; Narita, Masako; Narita, Masashi; Campbell, Fiona; Öhlund, Daniel; Pilarsky, Christian; Dow, Lukas E; Humbert, Patrick O; Biffi, Giulia; Tuveson, David A; Perez-Mancera, Pedro A.
Affiliation
  • Bermejo-Rodriguez C; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Araos Henríquez J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Caligiuri G; Cold Spring Harbor Laboratory, New York, New York.
  • Pinto Teles S; Lustgarten Foundation, Pancreatic Cancer Research Laboratory, New York, New York.
  • Park Y; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Evans A; Cold Spring Harbor Laboratory, New York, New York.
  • Barrera LN; Lustgarten Foundation, Pancreatic Cancer Research Laboratory, New York, New York.
  • Neesse A; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Grützmann R; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Aust D; Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.
  • Rümmele P; Department of Surgery, Universitätsklinikum Erlangen, Erlangen, Germany.
  • Knösel T; Institute for Pathology, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Narita M; Biobank Dresden, National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany.
  • Narita M; Institute of Pathology, Universitätsklinikum Erlangen, Erlangen, Germany.
  • Campbell F; Institute of Pathology, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.
  • Öhlund D; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Pilarsky C; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Dow LE; Department of Pathology, Royal Liverpool University Hospital, Liverpool, United Kingdom.
  • Humbert PO; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
  • Biffi G; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
  • Tuveson DA; Department of Surgery, Uniklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Perez-Mancera PA; Department of Biochemistry, Weill Cornell Medicine, New York, New York.
Cancer Res ; 84(18): 2968-2984, 2024 Sep 16.
Article de En | MEDLINE | ID: mdl-39037766
ABSTRACT
Perturbation of cell polarity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) progression. Scribble (SCRIB) is a well-characterized polarity regulator that has diverse roles in the pathogenesis of human neoplasms. To investigate the impact of SCRIB deficiency in PDAC development and progression, Scrib expression was genetically ablated in well-established mouse models of PDAC. Scrib loss in combination with KrasG12D did not influence development of pancreatic intraepithelial neoplasms in mice. However, Scrib deletion cooperated with KrasG12D and concomitant Trp53 heterozygous deletion to promote invasive PDAC and metastatic dissemination, leading to reduced overall survival. Immunohistochemical and transcriptome analyses revealed that Scrib-null tumors display a pronounced reduction of collagen content and an abundance of cancer-associated fibroblasts (CAF). Mechanistically, IL1α levels were reduced in Scrib-deficient tumors, and Scrib knockdown downregulated IL1α in mouse PDAC organoids (mPDO), which impaired CAF activation. Furthermore, Scrib loss increased YAP activation in mPDOs and established PDAC cell lines, enhancing cell survival. Clinically, SCRIB expression was decreased in human PDAC, and SCRIB mislocalization was associated with poorer patient outcome. These results indicate that SCRIB deficiency enhances cancer cell survival and remodels the tumor microenvironment to accelerate PDAC development and progression, establishing the tumor suppressor function of SCRIB in advanced pancreatic cancer.

Significance:

SCRIB loss promotes invasive pancreatic cancer development via both cell-autonomous and non-cell-autonomous processes and is associated with poorer outcomes, denoting SCRIB as a tumor suppressor and potential biomarker for the prediction of recurrence.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Carcinome du canal pancréatique / Protéines suppresseurs de tumeurs Langue: En Journal: Cancer Res / Cancer res / Cancer research Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Carcinome du canal pancréatique / Protéines suppresseurs de tumeurs Langue: En Journal: Cancer Res / Cancer res / Cancer research Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique